Latest Proteins Stories
The Firm’s Medtronic Infuse lawyers are investigating legal claims on behalf of individuals who suffered serious complications, including respiratory problems, cancer, nerve damage or wrongful death, allegedly due to Medtronic Infuse Bone Graft. New York, New York (PRWEB) April 06, 2013 The Medtronic Infuse lawyers at Bernstein Liebhard LLP note that a new report published by MassDevice.com predicts that hundreds of Medtronic Infuse Bone Graft lawsuits could ultimately be filed by...
In response to an article posted by IFT regarding the bodybuilding benefits of using rice protein versus whey protein, Muscular Development magazine affirms the advantages of using rice protein for vegetarians. Setauket, NY (PRWEB) April 04, 2013 On April 4, 2013, Muscular Development magazine responds to an article posted by the Institute of Food Technologists, which details a new study suggesting rice protein may be just as beneficial as whey protein for vegetarian bodybuilders....
The most common genetic cause of both ALS (amyotrophic lateral sclerosis) and FTD (frontotemporal dementia) was recently identified as an alteration in the gene C9orf72. But how the mutation causes neurodegenerative disease appeared mysterious. Researchers at Emory University School of Medicine have demonstrated that this ALS/FTD mutation may be harmful because it creates an "RNA sponge," soaking up an important regulatory protein that binds RNA. The results were published online Monday...
Most cancer treatments are blunt. In an attempt to eradicate tumors, oncologists often turn to radiation or chemotherapy, which can damage healthy tissue along with the cancerous growths. New research from C. David Allis' laboratory at Rockefeller University may bring scientists closer to designing cancer therapeutics that can target tumors with pinpoint accuracy. Their findings, published last week in Science Express, follow a recent series of discoveries by several international genome...
TOTOWA, N.J., and SAN FRANCISCO, March 25, 2013 /PRNewswire/ -- From the 2013 American College of Cardiology (ACC) Convention One of the leading complaints in the Emergency Department is chest pain and the timely detection of a heart attack is essential. Because of this, VectraCor, Inc., an emerging medical device company for cardiovascular solutions, is pleased to announce that The Johns Hopkins Hospital presented an abstract at the ACC conference in San Francisco that utilized...
In the future, artifical cells may produce complex protein structures on demand For years, scientists around the world have dreamed of building a complete, functional, artificial cell. Though this vision is still a distant blur on the horizon, many are making progress on various fronts. Prof. Roy Bar-Ziv and his research team in the Weizmann Institute’s Materials and Interfaces Department recently took a significant step in this direction when they created a two-dimensional, cell-like...
REHOVOT, Israel, March 18, 2013 /PRNewswire/ -- Proteologics [http://www.proteologics.com ] Ltd. (TASE: PRTL), a leading drug developer based on the ubiquitin system, announced today that, under the terms of the 3- year original collaboration agreement signed with GSK in March 2010, the parties have agreed to extend the collaboration for an additional year. Josh Levine, the CEO of Proteologics commented: "We are appreciative of the excellent working relationship and...
First-in-class chemical compound might control metastases It’s the spread of the original cancer tumor that kills most people. That’s why cancer researchers vigorously search for drugs that can prevent metastases, the spread of cancer. The research team co-led by Angela Wandinger-Ness, PhD, and Larry Sklar, PhD, at the University of New Mexico Cancer Center has found a chemical compound that appears to control cell migration and adhesion, two important characteristics of metastatic...
A better 'mousetrap' discovered in fruit flies might stop a human cancer-driving kinase in its tracks A seemingly obscure gene in the female fruit fly that is only active in cells that will become eggs has led researchers at the Stowers Institute for Medical Research to the discovery of a atypical protein that lures, traps, and inactivates the powerful Polo kinase, widely considered the master regulator of cell division. Its human homolog, Polo-like kinase-1 (Plk1), is misregulated in many...
SAN DIEGO, March 13, 2013 /PRNewswire/ -- Ceregene, Inc. today announced the completion of enrollment in its double-blind Phase 2 clinical study of CERE-110 (AAV-NGF), a gene therapy product designed to deliver nerve growth factor (NGF) for the treatment of Alzheimer's disease. The clinical study was carried out in collaboration with the Alzheimer's Disease Cooperative Study (ADCS) based at the University of California San Diego (UCSD) and funded by a grant from the National Institute...
